Tag: NYSE:PFE

September 24, 2019

The Unspoken Potential of Rosacea Treatments

Treatments for rosacea largely remain limited, but the market is growing in size. Here's what you need to know about...
September 19, 2019

Aerie Pharma Seeks FDA Nod to Sell Ireland-based Product in US

If the FDA grants Aerie Pharma approval, it will be able to manufacture Rocklatan in Ireland for sale in the...
September 12, 2019

5 Alzheimer’s Disease Treatment Stocks on the NASDAQ

A report from Reports and Data suggests the overall Alzheimer's market will be worth US$12.43 billion by 2026.
September 5, 2019

Investing in ADHD Treatments

The Investing News Network breaks down the key points you need to know about if you want to invest in...
August 28, 2019

10 Top Pharma Companies by Revenue

We break down the top pharma companies by revenue in 2018, according to information from research firm GlobalData.
August 15, 2019

10 Top Drug Sales to Watch Until 2024

Drug sales are expected to top US$1 trillion by 2024, even though a number of patents are set to expire...
August 12, 2019

Amgen Notches Patent Win for Enbrel Against Novartis

In response, Sandoz, a division of Novartis, said it will appeal the decision with the District Court of New Jersey.